Kenvue Inc. (NYSE:KVUE) Given Consensus Recommendation of “Hold” by Brokerages

Posted by Geri Gentry on Jul 23rd, 2026

Shares of Kenvue Inc. (NYSE:KVUE – Get Free Report) have been assigned a consensus rating of “Hold” from the sixteen brokerages that are currently covering the firm, MarketBeat.com reports. Thirteen investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $19.5833.

Several equities research analysts have recently issued reports on the stock. UBS Group raised their price target on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research note on Thursday, July 16th. Barclays boosted their price target on shares of Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Tuesday. Zacks Research downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 7th. Wall Street Zen upgraded shares of Kenvue to a “buy” rating in a research note on Sunday, July 12th. Finally, Citigroup lowered their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th.

Check Out Our Latest Analysis on KVUE

Kenvue Stock Performance

Shares of KVUE stock opened at $19.12 on Thursday. Kenvue has a one year low of $14.02 and a one year high of $22.87. The firm has a 50-day moving average of $18.30 and a 200-day moving average of $17.90. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. The company has a market cap of $36.71 billion, a P/E ratio of 22.49, a P/E/G ratio of 1.44 and a beta of 0.47.

Kenvue (NYSE:KVUE – Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. During the same quarter in the previous year, the business earned $0.24 EPS. The company’s revenue was up 4.5% compared to the same quarter last year. Equities research analysts forecast that Kenvue will post 1.16 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were paid a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date was Wednesday, May 13th. Kenvue’s payout ratio is presently 97.65%.

Insider Transactions at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 1.59% of the company’s stock.

Institutional Investors Weigh In On Kenvue

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Merit Financial Group LLC boosted its position in shares of Kenvue by 15.7% in the second quarter. Merit Financial Group LLC now owns 77,208 shares of the company’s stock valued at $1,475,000 after acquiring an additional 10,483 shares during the period. Corecam AG purchased a new stake in Kenvue in the 2nd quarter worth approximately $344,000. Rosenberg Matthew Hamilton lifted its stake in Kenvue by 341.9% in the 2nd quarter. Rosenberg Matthew Hamilton now owns 3,045 shares of the company’s stock worth $58,000 after purchasing an additional 2,356 shares in the last quarter. Farther Finance Advisors LLC boosted its holdings in Kenvue by 6.5% in the 2nd quarter. Farther Finance Advisors LLC now owns 68,743 shares of the company’s stock valued at $1,314,000 after purchasing an additional 4,184 shares during the period. Finally, Ballentine Partners LLC boosted its holdings in Kenvue by 6.0% in the 2nd quarter. Ballentine Partners LLC now owns 18,477 shares of the company’s stock valued at $353,000 after purchasing an additional 1,052 shares during the period. 97.64% of the stock is currently owned by institutional investors.

About Kenvue

(Get Free Report)

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.